CAS 952654-62-5
:(3R,4R,5R,6R)-6-[4-[(4-fluorphenyl)methylcarbamoyl]-1-methyl-2-[1-methyl-1-[(5-methyl-1,3,4-oxadiazol-2-carbonyl)amino]ethyl]-6-oxo-pyrimidin-5-yl]oxy-3,4,5-trihydroxy-tetrahydropyran-2-carboxylsäure
Raltegravir Glucuronide
CAS:Formel:C26H29FN6O11Farbe und Form:White To Off-White SolidMolekulargewicht:620.55Raltegravir beta-D-glucuronide
CAS:Applications A metabolite of Raltegravir.
References Bosma, P., et al.: J. Biol. Chem., 269, 17960 (1994), Richman, D., et al.: Nature, 410, 995 (2001), Williams, J., et al.: Drug Metab. Dispos., 32, 1201 (2004), Miners, J., et al.: Biochem. Pharmacol., 71, 1531 (2006),Formel:C26H29FN6O11Farbe und Form:NeatMolekulargewicht:620.54Raltegravir-d3 b-D-Glucuronide (>90%)
CAS:Kontrolliertes ProduktApplications A labelled metabolite of Raltegravir.
References Bosma, P., et al.: J. Biol. Chem., 269, 17960 (1994) , Richman, D., et al.: Nature, 410, 995 (2001), Williams, J., et al.: Drug Metab. Dispos., 32, 1201 (2004), Miners, J., et al.: Biochem. Pharmacol., 71, 1531 (2006),Formel:C26H26D3FN6O11Reinheit:>90%Farbe und Form:NeatMolekulargewicht:623.56Raltegravir b-D-glucuronide
CAS:Raltegravir b-D-glucuronide is a synthetic, fluorinated analog of raltegravir. It is a potent HIV-1 integrase inhibitor that has been shown to be active against the majority of HIV-1 strains. Raltegravir b-D-glucuronide is less potent than the parent compound and exhibits reduced antiviral activity in vitro. Raltegravir b-D-glucuronide is metabolized to raltegravir and eliminated in urine as the glucuronide conjugate.
Formel:C26H29FN6O11Reinheit:Min. 95%Farbe und Form:White PowderMolekulargewicht:620.54 g/mol




